BioDelivery's cancer pain drug Onsolis set for launch in Canada
This article was originally published in Scrip
Executive Summary
BioDelivery Sciences International said that its drug for breakthrough cancer pain, Onsolis (fentanyl buccal soluble film), is set for a launch in Canada this quarter.